Literature DB >> 20471844

Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.

María Laura Lavaggi1, Mauricio Cabrera, María de Los Angeles Aravena, Claudio Olea-Azar, Adela López de Ceráin, Antonio Monge, Gisela Pachón, Marta Cascante, Ana María Bruno, Lía I Pietrasanta, Mercedes González, Hugo Cerecetto.   

Abstract

Phenazine 5,10-dioxides are prodrugs for antitumor therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here we investigate the expanded system benzo[a]phenazine 7,12-dioxides as selective hypoxic cytotoxin-scaffold. The clonogenic survival of V79 cells on aerobic and anaerobic conditions, conduct us to study antiproliferative activity on Caco-2 tumoral cells in normoxia. Electrochemical, DNA-interaction and DNA-damage studies were performed to establish the mode of action. The results demonstrated the potential biological properties of the studied scaffold being derivatives 6-10 structural hits for further chemical-modifications to become into therapeutics for solid tumors. Compounds 6 and 8 with cytotoxicity against V79 cells in both conditions (aerobia and anaerobia) were also cytotoxic against Caco-2 tumoral cells in aerobiosis. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471844     DOI: 10.1016/j.bmc.2010.04.074

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo.

Authors:  María L Lavaggi; Mauricio Cabrera; Cristina Pintos; Carolina Arredondo; Gisela Pachón; Jorge Rodríguez; Stella Raymondo; José Pedro Pacheco; Marta Cascante; Claudio Olea-Azar; Adela López de Ceráin; Antonio Monge; Hugo Cerecetto; Mercedes González
Journal:  ISRN Pharmacol       Date:  2011-06-22

2.  Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer.

Authors:  Nicole Lecot; Belén Dávila; Carina Sánchez; Marcelo Fernández; Mercedes González; Pablo Cabral; Hugo Cerecetto; Romina Glisoni
Journal:  Polymers (Basel)       Date:  2021-12-25       Impact factor: 4.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.